Back to search

Article

Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine Investigation

2019-05-27

Abstract excerpt

DNA vaccines are stable, safe, cost effective to produce and relatively quick and easy to manufacture. However, to date DNA vaccines have shown relatively poor immunogenicity in humans despite promising preclinical results. Consequently, a number of different approaches have been investigated to improve the immunogenicity of DNA vaccines. These include the use of improved delivery methods, adjuvants, stronger prom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e65504df-94a6-593d-801a-7e12321a64c6
DOI
10.20944/preprints201905.0310.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of a Novel Enhanced DNA Vaccine Vector for Preclinical Virus Vaccine InvestigationDOI 10.20944/preprints201905.0310.v1
Select a neighboring publication to make it the new centre.